Innovation
We invest in start-ups that transfer promising scientific findings into real-life applications.
We invest in the visions of today to make them a reality tomorrow. Our investments in deep tech start-ups bring scientific research results to the people.
As an owner-managed venture capital investor, we finance spin-offs from scientific research whose innovations generate concrete solutions for a variety of social challenges and create added value for society.
We accompany our portfolio companies over the long term – both financially as well as with our extensive experience and strong entrepreneurial mindset. We invest our own money, make decisions based on the sustainable potential for success, and enable founding teams to achieve outstanding results.
We lead innovations to success. We do it the OCCIDENT Way.
Chief Executive Officer (CEO)
Heads OCCIDENT, defines the business strategy, brings inspiration and always maintains the overview; supports all investment decisions and is responsible for finance, human resources and marketing.
Studied economics in Vienna, has experience in marketing in international companies (Internet, consumer goods) and as a real estate and venture capital investor for many years.
Chief Investment Officer (CIO)
Heads investment management, supervises all investment cases until closing, defines the terms and brings an entrepreneurial mindset to portfolio management; supports all investment decisions and is responsible for controlling.
Studied economics in Vienna, has experience in controlling at international companies (food products, telecommunications) and as a venture capital investor for many years.
Senior Investment Manager
Always looking for the most promising and most innovative technologies and startups in the life sciences sector; responsible for deal sourcing, due diligence and active portfolio management. Leads the life sciences team.
Studied pharmaceuticals and economics in Zurich, many years of experience in private equity and venture capital.
Junior Investment Manager
Passionate about disruptive innovations in the life sciences and biotechnology sectors. Responsible for deal sourcing, due diligence and portfolio building.
Master’s degree in Management from TU Munich and chemistry studies in Linz. Previous professional experience as an innovation consultant and as an executive in a German fintech start-up with focus on financing sustainable projects and start-ups.
Our activity as a venture capital investor is based on Patrizia and Michael’s fascination for innovative technologies and ground-breaking scientific findings. As entrepreneurs, they laid the foundations in 2012 for investing in such technologies and thus financing their development into products with a concrete added value for patients and customers.
Origins as venture capital investor in Switzerland
Team expansion with 1st investment manager, focus on the life sciences field, 1st exit
1st venture capital investment in Germany
OCCIDENT portfolio comprises >10 start-ups
OCCIDENT’s 2nd location in Munich
1st investment manager for the industrial tech sector
Munich location becomes OCCIDENT’s new head office
1st investment in the industrial tech sector
OCCIDENT portfolio with >25 start-ups and >5 exits
The Science Investor.